
<DOC>
<DOCNO>
WSJ900409-0079
</DOCNO>
<DOCID>
900409-0079.
</DOCID>
<HL>
   Who's News:
   Merck &amp; Co.
</HL>
<DATE>
04/09/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE B4
</SO>
<CO>
   MRK WNEWS
</CO>
<LP>
   MERCK &amp; Co. (Rahway, N.J.) -- Michael M. Tarnow was named
president of this pharmaceuticals and health-care company's
Merck Frosst Canada Inc. division. He succeeds Robert Ingram,
46 years old, who recently left to join Glaxo PLC. Mr.
Tarnow, 48, most recently was executive director, corporate
development, for the parent and was responsible for
initiating, implementing and coordinating the corporatewide
development program.
</LP>
<TEXT>
</TEXT>
</DOC>